Methylprednisolone Terminated Phase 2 Trials for Spondylarthropathy Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01216631Seronegative Oligoarthritis of the Knee Study (SOKS)